logo
Breadcrumbs Image

Oral Vaccine Market

Oral Vaccine Market

Global Oral Vaccine Market Research Report 2021 Professional Edition


Date: Apr-2021 | Id: MACRC-48574 | Geographical Scope: Global | Publisher: HNY Research

The research team projects that the Oral Vaccine market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Merck
Bibcol
Lanzhou Institute
GSK
Shanghai United Cell
Sanofi
Vabiotech
Valneva
Serum Institute
PaxVax
Halfkin Bio-Pharmaceuticals
Tiantan Biological
Bio-Med
EuBiologics
Panacea Biotec Ltd

By Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others

By Application
Public
Private

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Oral Vaccine 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Oral Vaccine Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Oral Vaccine Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oral Vaccine market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Oral Vaccine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Rotavirus Vaccine
1.4.3 Cholera Vaccine
1.4.4 Oral Polio Vaccine
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Vaccine Market Share by Application: 2022-2027
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Oral Vaccine Market
1.8.1 Global Oral Vaccine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Oral Vaccine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Oral Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oral Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oral Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Oral Vaccine Sales Volume Market Share by Region (2016-2021)
3.2 Global Oral Vaccine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Oral Vaccine Sales Volume
3.3.1 North America Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Oral Vaccine Sales Volume
3.4.1 East Asia Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Oral Vaccine Sales Volume (2016-2021)
3.5.1 Europe Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Oral Vaccine Sales Volume (2016-2021)
3.6.1 South Asia Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Oral Vaccine Sales Volume (2016-2021)
3.7.1 Southeast Asia Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Oral Vaccine Sales Volume (2016-2021)
3.8.1 Middle East Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Oral Vaccine Sales Volume (2016-2021)
3.9.1 Africa Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Oral Vaccine Sales Volume (2016-2021)
3.10.1 Oceania Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Oral Vaccine Sales Volume (2016-2021)
3.11.1 South America Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Oral Vaccine Sales Volume (2016-2021)
3.12.1 Rest of the World Oral Vaccine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Oral Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Oral Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Oral Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Oral Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Oral Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Oral Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Oral Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Oral Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Oral Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Oral Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Oral Vaccine Sales Volume Market Share by Type (2016-2021)
14.2 Global Oral Vaccine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Oral Vaccine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Oral Vaccine Consumption Volume by Application (2016-2021)
15.2 Global Oral Vaccine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Oral Vaccine Business
16.1 Merck
16.1.1 Merck Company Profile
16.1.2 Merck Oral Vaccine Product Specification
16.1.3 Merck Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Bibcol
16.2.1 Bibcol Company Profile
16.2.2 Bibcol Oral Vaccine Product Specification
16.2.3 Bibcol Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Lanzhou Institute
16.3.1 Lanzhou Institute Company Profile
16.3.2 Lanzhou Institute Oral Vaccine Product Specification
16.3.3 Lanzhou Institute Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 GSK
16.4.1 GSK Company Profile
16.4.2 GSK Oral Vaccine Product Specification
16.4.3 GSK Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Shanghai United Cell
16.5.1 Shanghai United Cell Company Profile
16.5.2 Shanghai United Cell Oral Vaccine Product Specification
16.5.3 Shanghai United Cell Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Sanofi
16.6.1 Sanofi Company Profile
16.6.2 Sanofi Oral Vaccine Product Specification
16.6.3 Sanofi Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Vabiotech
16.7.1 Vabiotech Company Profile
16.7.2 Vabiotech Oral Vaccine Product Specification
16.7.3 Vabiotech Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Valneva
16.8.1 Valneva Company Profile
16.8.2 Valneva Oral Vaccine Product Specification
16.8.3 Valneva Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Serum Institute
16.9.1 Serum Institute Company Profile
16.9.2 Serum Institute Oral Vaccine Product Specification
16.9.3 Serum Institute Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 PaxVax
16.10.1 PaxVax Company Profile
16.10.2 PaxVax Oral Vaccine Product Specification
16.10.3 PaxVax Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Halfkin Bio-Pharmaceuticals
16.11.1 Halfkin Bio-Pharmaceuticals Company Profile
16.11.2 Halfkin Bio-Pharmaceuticals Oral Vaccine Product Specification
16.11.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Tiantan Biological
16.12.1 Tiantan Biological Company Profile
16.12.2 Tiantan Biological Oral Vaccine Product Specification
16.12.3 Tiantan Biological Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Bio-Med
16.13.1 Bio-Med Company Profile
16.13.2 Bio-Med Oral Vaccine Product Specification
16.13.3 Bio-Med Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 EuBiologics
16.14.1 EuBiologics Company Profile
16.14.2 EuBiologics Oral Vaccine Product Specification
16.14.3 EuBiologics Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Panacea Biotec Ltd
16.15.1 Panacea Biotec Ltd Company Profile
16.15.2 Panacea Biotec Ltd Oral Vaccine Product Specification
16.15.3 Panacea Biotec Ltd Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Oral Vaccine Manufacturing Cost Analysis
17.1 Oral Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Oral Vaccine
17.4 Oral Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Oral Vaccine Distributors List
18.3 Oral Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Oral Vaccine (2022-2027)
20.2 Global Forecasted Revenue of Oral Vaccine (2022-2027)
20.3 Global Forecasted Price of Oral Vaccine (2016-2027)
20.4 Global Forecasted Production of Oral Vaccine by Region (2022-2027)
20.4.1 North America Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.9 South America Oral Vaccine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Oral Vaccine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Oral Vaccine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Oral Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Oral Vaccine by Country
21.3 Europe Market Forecasted Consumption of Oral Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Oral Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Oral Vaccine by Country
21.6 Middle East Forecasted Consumption of Oral Vaccine by Country
21.7 Africa Forecasted Consumption of Oral Vaccine by Country
21.8 Oceania Forecasted Consumption of Oral Vaccine by Country
21.9 South America Forecasted Consumption of Oral Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Oral Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Add to Cart

Single User

$ 2890.00

Site License

$ 4335.00

Enterprisewide

$ 5780.00